You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune dysregulation syndromes

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Allergy and Immunology Natural History Study

Recruiting
  • Immune Deficiency
  • +2 more
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Oct 14, 2022

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Immunosuppression Only Conditioning
    • +3 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    Immune Dysregulation in Patients With COVID-19

    Recruiting
    • COVID-19
    • Immunosuppression
    • mid covid-19 patients
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jan 6, 2023

    Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

    Recruiting
    • Primary Immune Deficiency Disorder
    • +2 more
    • Baltimore, Maryland
      Johns Hopkins University
    Oct 20, 2022

    Genetic Analysis of Immune Disorders

    Recruiting
    • DOK 8
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 27, 2023

      Individuals With and Without Immune Deficiencies and

      Recruiting
      • Immunodeficiencies
      • Immune Dysregulations
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 6, 2023

        Auto-immune Encephalitis and Neurological Paraneoplastic

        Active, not recruiting
        • Paraneoplastic Neurological Syndrome
        • Autoimmune Encephalitis
        • Test of biological samples
        • Lyon, France
          Centre de référence des syndromes neurologiques paranéoplasiques
        Feb 12, 2023

        Immune-response in Autoimmune Encephalitis and Paraneoplastic

        Recruiting
        • Autoimmune Encephalitis
        • Paraneoplastic Neurological Syndrome
        • Genetic and immunology tests
        • Lyon, France
          Centre de référence des syndromes neurologiques paranéoplasiques
        Mar 6, 2023

        CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term

        Completed
        • Paraneoplastic Syndromes
        • This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
        • Lyon, France
          Centre de référence des syndromes neurologiques paranéoplasiques
        Jul 11, 2023

        Common Variable Immunodeficiency and Related Syndromes

        Recruiting
        • CVID
        • XLA
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

          Recruiting
          • Autoimmune Hemolytic Anemia
          • +5 more
          • cytokine essays
          • +6 more
          • Milano, Italy
            Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
          Jul 3, 2023

          Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

          Recruiting
          • Immune Thrombocytopenia
          • +3 more
          • potential biomarkers
          • Graz, Styria, Austria
            Pediatric Hematology-Oncology Outpatient Clinic
          Sep 8, 2022

          Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)

          Not yet recruiting
          • Long COVID-19
          • Long COVID
          • Paxlovid 25 day dosing
          • +2 more
          • (no location specified)
          Jul 25, 2023

          Interplay Between Immune and Metabolic Programs in

          Recruiting
          • Myelodysplastic Syndromes
            • Toulouse, France
              IUCT-Oncopole University Hospital
            May 17, 2022

            Unknown or Incompletely Characterized Immune Defects

            Recruiting
            • Immunodeficiency
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jul 20, 2022

              Disorders With Increased Susceptibility to Fungal Infections

              Recruiting
              • Fungal Infections
              • Primary Immune Deficiencies
                • Bethesda, Maryland
                  National Institutes of Health Clinical Center
                Jan 18, 2023

                Lymphadenitis, Tuberculous, Immune Defect Trial in Surabaya (Immuno-histochemical staining)

                Completed
                • Lymphadenitis, Tuberculous
                • Immune Defect
                • Immuno-histochemical staining
                • Surabaya, East Java, Indonesia
                  Vincentius A Paulo Surabaya Hospital
                Jan 8, 2022

                Antibodies Causing Epilepsy Syndromes: The ACES Study.

                Completed
                • Auto-immune Encephalitis
                • Epilepsy
                • vena punction
                • Heemstede, Netherlands
                • +7 more
                Jul 27, 2022

                Immune-mediated Diseases

                Recruiting
                • Primary Immunodeficiency
                • +3 more
                  • Bethesda, Maryland
                    National Institutes of Health Clinical Center
                  Jan 10, 2023

                  Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases Trial run by the NCI (drug, radiation,

                  Recruiting
                  • Lymphoproliferative Disorders
                  • +4 more
                  • Busulfan test dose
                  • +8 more
                  • Bethesda, Maryland
                    National Institutes of Health Clinical Center
                  Jan 23, 2023

                  Immune Tolerance Breakdown in HU-autoimmunity

                  Active, not recruiting
                  • Immune Tolerance
                  • Description of clinical, immunological and tumor features of patients harboring Hu Abs
                  • Lyon, France
                    Centre de référence des syndromes neurologiques paranéoplasiques
                  Feb 23, 2023

                  Immuno-Deficiency Trial in Caen (Systematic screening of immune deficiency)

                  Completed
                  • Immuno-Deficiency
                  • Systematic screening of immune deficiency
                  • Caen, France
                    Caen University Hospital
                  Nov 28, 2022

                  Neurological Immune-related Adverse Events

                  Recruiting
                  • Neurological Disease
                  • Analysis of biomarkers and their correlation with clinical characteristics and outcome
                  • Bron, France
                    Centre de référence des syndromes neurologiques paranéoplasiques
                  Jul 28, 2023

                  Immune Effector Cell-Associated Neurotoxicity Syndrome

                  Not yet recruiting
                  • Immune Effector Cell Associated Neurotoxicity Syndrome
                    • (no location specified)
                    Dec 1, 2022